Published on Medical Design Technology (http://www.mdtmag.com)

Home > Synageva finds $25M financing for enzyme treatment

Synageva finds $25M financing for enzyme treatment

Mass High Tech: The Journal of New England Technology

Synageva BioPharma Corp. has landed a $25 million private equity funding to support development of the Lexington biotech’s enzyme replacement therapy, SBC-102.

The $25 million brings the company’s funding up to $70 million in the last two and a half years.

SOURCE [1]

Source URL (retrieved on 05/18/2013 - 9:03pm): http://www.mdtmag.com/news/2011/03/synageva-finds-25m-financing-enzyme-treatment

Links:
[1] http://www.masshightech.com/stories/2011/03/21/daily5-Synageva-finds-25M-financing-for-enzyme-treatment.html